FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Furosemide Injection Recall

Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc

Hospira, Inc. · Rocky Mount, NC

Risk level
Class II
Reported by FDA
Mar 6, 2013
Recall ID
D-169-2013
Check your lot numberHow we source this data

Summary

Hospira recalled Furosemide Injection starting Jan 10, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-169-2013 on Mar 6, 2013. Reason: Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial

Product description

Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04

Lot numbers, UPCs & expiration codes

18-099-DK

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-169-2013
Classification
Class II
Status
Terminated
Recall initiated
Jan 10, 2013
FDA report date
Mar 6, 2013
Quantity
63,900 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira, Inc.

Original FDA data

Every field from FDA enforcement report D-169-2013, exactly as published.

Show all FDA fields
City
Rocky Mount
State
NC
Status
Terminated
Country
United States
Event ID
64083
Address
Hwy. 301 N. + 4285 North Wesleyan Blvd.
Code information
18-099-DK
Postal code
27804
Report date
Mar 6, 2013
Product type
Drugs
Recall number
D-169-2013
Classification
Class II
Recalling firm
Hospira, Inc.
Product quantity
63,900 vials
Termination date
Oct 8, 2014
Reason for recall
Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial
Voluntary / mandated
Voluntary: Firm initiated
Product description
Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04
Distribution pattern
Nationwide
Recall initiation date
Jan 10, 2013
Initial firm notification
Letter
Center classification date
Feb 26, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-169-2013, published Mar 6, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls